4-[3-Amino-3-(2,3-dihydro-1,4-benzodioxin-3-yl)propoxy]benzenesulfonamide (DPP IV/hCA II-IN-1) is a potent and selective inhibitor of dipeptidyl peptidase IV (DPP IV) and carbonic anhydrase (CA), with potential therapeutic applications in conditions where modulation of DPP IV and/or CA activity is beneficial, such as type 2 diabetes, glaucoma, epilepsy, and certain cancers.